BioInvent International AB banner

Intrinsic Value

The intrinsic value of BioInvent International AB (BIX0) under the Base Case is 0.66 EUR per share. Compared with the current market price of 0.257 EUR, the stock appears Undervalued by 61% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

BIX0 Intrinsic Value
€0.66
Undervaluation 61%
Intrinsic Value
Price €0.257
Alert me when BIX0 is below its intrinsic value
Today €0.528 · Already reached, the price is 51.3% below it

BIX0 is cheaper than usual. It was this cheap or cheaper on less than 1% of days in the past 5 years.

Alternatives to BIX0

Fundamental Analysis

What BioInvent International AB Does

Biotechnology Health Care

BioInvent International AB is a Swedish biotech company that discovers and develops antibody-based medicines, mainly for cancer. It does not sell consumer products; instead, it creates drug candidates and research tools that are meant to be tested in clinical studies and then licensed or partnered with larger drugmakers. Its work centers on finding antibodies that can help the immune system attack tumors or block signals that cancer cells use to grow.

Headquarters
Sweden SE
Employees
112
IPO date
Jun 12, 2001
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue BIX0 Research

Decided on BioInvent International? Get an email when BIX0 reaches the price you’d buy at. Free with an account.

Other BioInvent International listings

What is the Intrinsic Value of one BIX0 stock?

The intrinsic value for BioInvent International AB (BIX0) under the Base Case is 0.66 EUR.

Is BIX0 stock undervalued or overvalued?

Compared with the current market price of 0.257 EUR, the stock appears Undervalued by 61% .

How reliable are our estimates? See how past valuations played out
Back to Top